Cue Biopharma, Inc. (CUE) Cash flow
Market cap
$1.4B
P/E ratio
| 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Stock-based compensation | 7 | 7 | 10 | 12 | 9 | 8 | 7 |
| Cash from operations | -26,410,968 | -30,796,910 | -32,494,034 | -38,837,166 | -41,805,954 | -40 | -36 |
| Capital expenditures | -1,854,246 | -46,353 | -595,259 | -913,039 | -170,746 | - | -0 |
| Cash from investing | -20,354,246 | 3 | 4 | 9 | -24,609,877 | 25 | 0 |
| Repurchases of common stock | - | 91,027 | 271,051 | 750,183 | 199,873 | - | - |
| Cash from financing | 4 | 51 | 59 | 19 | 54 | 12 | 10 |
| Free cash flow | - | ||||||
| FCF margin (%) | - |